Replies to post #113034 on Biotech Values

[DewDiligence]

NVS licenses Griffols’ immunohematology diagnostics for US market:

http://finance.yahoo.com/news/Grifols-Signs-Cooperative-prnews-402004414.html?x=0&.v=1

Diagnostics is currently a very small business for NVS, but management considers it a growth area, and the business was recently bolstered with the acquisition of GXDX (#msg-59092015).

Griffols, based in Spain, is one of the world’s leading plasma-protein companies and is in the process of acquiring TLCR (#msg-50961841).